Bangladesh exports pharmaceuticals to over 100 countries, but exports to the U.S. remain modest — just $20 million out of $210 million in FY2023. Former U.S. President Donald Trump’s threat of a 100% tariff on drug imports now casts uncertainty over expansion into this key market. Industry experts suggest Bangladesh may face both challenges and opportunities: while competitors like India and China could be hit harder, new openings may emerge for Bangladeshi producers. CPD Research Director Dr. Khandaker Golam Moazzem warned that higher tariffs would increase consumer costs and create new competition in alternative markets.